Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Income towards Parent Company: 2019-2024

Historic Income towards Parent Company for IDEAYA Biosciences (IDYA) over the last 6 years, with Dec 2024 value amounting to -$327.0 million.

  • IDEAYA Biosciences' Income towards Parent Company rose 262.13% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$167.5 million, marking a year-over-year increase of 25.47%. This contributed to the annual value of -$327.0 million for FY2024, which is 143.23% down from last year.
  • Latest data reveals that IDEAYA Biosciences reported Income towards Parent Company of -$327.0 million as of FY2024, which was down 143.23% from -$134.4 million recorded in FY2023.
  • In the past 5 years, IDEAYA Biosciences' Income towards Parent Company ranged from a high of -$35.3 million in FY2020 and a low of -$327.0 million during FY2024.
  • Its 3-year average for Income towards Parent Company is -$174.6 million, with a median of -$134.4 million in 2023.
  • As far as peak fluctuations go, IDEAYA Biosciences' Income towards Parent Company increased by 20.16% in 2020, and later slumped by 143.23% in 2024.
  • Over the past 5 years, IDEAYA Biosciences' Income towards Parent Company (Yearly) stood at -$35.3 million in 2020, then plummeted by 42.22% to -$50.3 million in 2021, then dropped by 24.34% to -$62.5 million in 2022, then crashed by 115.08% to -$134.4 million in 2023, then slumped by 143.23% to -$327.0 million in 2024.